Peritoneal Cancer
📧 Sign up to get email alerts when something new happens for Peritoneal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
Clinical trial update reporting results from a Phase 1/2 study of ruxolitinib phosphate in combination with paclitaxel and carboplatin for S…
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: P53MVA and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating the P53MVA vaccine with pembrolizumab for recurrent platinum-resistant ovarian cancer, fallopian tube cancer, or pr…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer [Phase 1]
A Phase 1 trial assessing the safety and biological activity of IP IMNN-001 (GEN-1) with neoadjuvant chemotherapy in epithelial ovarian canc…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma) [Phase 2]
Phase 2 Imperial College London study evaluating dual mTORC1/2 inhibition in advanced or recurrent epithelial ovarian, fallopian tube, or pr…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer. [Phase 1]
Phase I study of Cantrixil in ovarian, fallopian tube, and primary peritoneal cancers has completed. Results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors [Phase 1]
Phase 1 study shows safety, pharmacokinetics and preliminary anti-tumor activity of RP12146 in patients with solid tumors, including extensi…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning Regimen in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluating NY-ESO-1 TCR-engineered T cells with hematopoietic stem cells after melphalan conditioning in recurrent or refrac…
-
CLINICAL_TRIALS trial_result · 2024-09-05Clinical Trial Update: "Re-Stimulated" TILs and IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 clinical trial evaluating re-stimulated tumor-infiltrating lymphocytes (TILs) with interleukin-2 for platinum-resistant recurrent ca…
-
CLINICAL_TRIALS trial_result · 2024-08-29Clinical Trial Update: Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 trial evaluated pembrolizumab in combination with carboplatin and paclitaxel for Stage III–IV ovarian, primary peritoneal, or fall…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 trial of a cancer vaccine therapy combined with cyclophosphamide for patients with Stage II-III breast cancer or Stage II-IV ovarian…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Intraperitoneal Infusion of ex Vivo-cultured Allogeneic NK Cells in Recurrent Ovarian Carcinoma Patients [Phase 1]
Phase 1 trial update on intraperitoneal infusion of ex vivo-cultured allogeneic NK cells in patients with recurrent ovarian cancer, recurren…
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression [Phase 3]
A Phase 3 study of mirvetuximab soravtansine in platinum-resistant, high-FRα epithelial ovarian, primary peritoneal, or fallopian tube cance…
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression [Phase 3]
Phase 3 trial comparing mirvetuximab soravtansine with investigator's choice chemotherapy in FRα-high, platinum-resistant epithelial ovarian…
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: A Study of PF-06873600 in People With Cancer [Phase 1, Phase 2]
Pfizer's PF-06873600 in Phase 1/2 for several cancers was terminated, with results posted in July 2024.
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers [Phase 1]
Phase 1 clinical trial evaluating nab-paclitaxel in combination with bevacizumab in patients with unresectable stage IV melanoma or gynecolo…
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer [Phase 1]
This Phase 1 trial update reports completion of a study evaluating weekly paclitaxel with oncothermia and weekly cisplatin with oncothermia …
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating neo-adjuvant pembrolizumab in primary stage IV ovarian cancer with peritoneal or fallopian tube involvement. The …
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab [Phase 2]
Phase 2 trial evaluating weekly ixabepilone with or without biweekly bevacizumab in epithelial ovarian cancer and related peritoneal cancers…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer [NA]
The LCC-CARIS-01 trial focusing on molecular profiling in gynecologic cancers has completed. The study included epithelial ovarian cancer, p…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib [Phase 3]
Phase 3 rollover study CATCH-R provides continued access to rucaparib for eligible patients with metastatic castration-resistant prostate ca…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer [Phase 1]
The Phase 1 study of KHK2866, an HB-EGF–targeting antibody, in advanced solid tumors and ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial of DSP-7888 Dosing Emulsion in combination with immune checkpoint inhibitors in adults with advanced solid tumors was termin…
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab in participants with recurrent ovarian, fallopian tube, or primary peritoneal carcinoma.
-
CLINICAL_TRIALS trial_result · 2024-02-14Clinical Trial Update: Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating mirvetuximab soravtansine in combination with bevacizumab, carboplatin, pegylated liposomal doxorubicin, or pem…
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor [Phase 2]
Phase 2 clinical trial evaluating a genetic profile–guided treatment strategy for ovarian cancer patients who previously received a PARP inh…